RD

Robert Day

NA Novartis Ag: 3 patents #1,476 of 5,128Top 30%
Pfizer: 3 patents #1,612 of 5,153Top 35%
SS Socpra Sciences Santé Et Humaines S.E.C.: 1 patents #10 of 32Top 35%
📍 Sherbrooke, CA: #60 of 670 inventorsTop 9%
Overall (All Time): #569,985 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
9809621 Stable peptide-based PACE4 inhibitors Witold A. Neugebauer, Yves Dory 2017-11-07
9789118 Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof David Barnes, Gregory Raymond Bebernitz, Kevin Clairmont, Scott Louis Cohen, Robert E. Damon, II +11 more 2017-10-17
9573974 Multi-leu peptides and analogues thereof as selective PACE4 inhibitors and effective antiproliferative agents Martin Fugére, Witold A. Neugebauer 2017-02-21
8697739 Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof David Barnes, Gregory Raymond Bebernitz, Kevin Clairmont, Scott Louis Cohen, Robert E. Damon, II +11 more 2014-04-15
8658591 Multi-LEU peptides and analogues thereof as selective PACE4 inhibitors and effective antiproliferative agents Martin Fugére, Witold A. Neugebauer 2014-02-25
8394858 Cyclohexane derivatives and uses thereof David Barnes, Gregory Raymond Bebernitz, Scott Louis Cohen, Robert E. Damon, II, Monish JAIN +6 more 2013-03-12
6706743 &bgr;3 adrenergic receptor agonists and uses thereof Jennifer Lafontaine 2004-03-16
6608203 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists Kimberly O. Cameron, Richard Chesworth, Paul DaSilva-Jardine, Bruce Lefker, Michael P. Zawistoski 2003-08-19
6566377 &bgr;3 adrenergic receptor agonists and uses thereof Jennifer Lafontaine 2003-05-20